Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf

Anti-apoptotic Bcl-2 family members are critical for the regulation of haematopoietic stem and progenitor cell (HSPC) survival. Little is known about the role of their pro-apoptotic antagonists, i.e. ‘BH3-only’ proteins, in this cell compartment. Based on the analysis of cytokine deprivation-induced...

Full description

Bibliographic Details
Main Authors: Labi, Verena, Bertele, Daniela, Woess, Claudia, Tischner, Denise, Bock, Florian J, Schwemmers, Sven, Pahl, Heike L, Geley, Stephan, Kunze, Mirjam, Niemeyer, Charlotte M, Villunger, Andreas, Erlacher, Miriam
Format: Online
Language:English
Published: WILEY-VCH Verlag 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569658/
id pubmed-3569658
recordtype oai_dc
spelling pubmed-35696582013-02-12 Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf Labi, Verena Bertele, Daniela Woess, Claudia Tischner, Denise Bock, Florian J Schwemmers, Sven Pahl, Heike L Geley, Stephan Kunze, Mirjam Niemeyer, Charlotte M Villunger, Andreas Erlacher, Miriam Research Articles Anti-apoptotic Bcl-2 family members are critical for the regulation of haematopoietic stem and progenitor cell (HSPC) survival. Little is known about the role of their pro-apoptotic antagonists, i.e. ‘BH3-only’ proteins, in this cell compartment. Based on the analysis of cytokine deprivation-induced changes in mRNA expression levels of Bcl-2 family proteins, we determined the consequences of BH3-only protein depletion on HSPC survival in culture and, for selected candidates, on engraftment in vivo. Thereby, we revealed a critical role for Bim and Bmf as regulators of HSPC dynamics both during early engraftment and long-term reconstitution. HSPCs derived from wild-type donors were readily displaced by Bim- or Bmf-deficient or Bcl-2-overexpressing HSPCs as early as 10 days after engraftment. Moreover, in the absence of Bim, significantly lower numbers of transplanted HSPCs were able to fully engraft radio-depleted recipients. Finally, we provide proof of principle that RNAi-based reduction of BIM or BMF, or overexpression of BCL-2 in human CD34+ cord blood cells may be an attractive therapeutic option to increase stem cell survival and transplantation efficacy. WILEY-VCH Verlag 2013-01 2012-11-24 /pmc/articles/PMC3569658/ /pubmed/23180554 http://dx.doi.org/10.1002/emmm.201201235 Text en Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Labi, Verena
Bertele, Daniela
Woess, Claudia
Tischner, Denise
Bock, Florian J
Schwemmers, Sven
Pahl, Heike L
Geley, Stephan
Kunze, Mirjam
Niemeyer, Charlotte M
Villunger, Andreas
Erlacher, Miriam
spellingShingle Labi, Verena
Bertele, Daniela
Woess, Claudia
Tischner, Denise
Bock, Florian J
Schwemmers, Sven
Pahl, Heike L
Geley, Stephan
Kunze, Mirjam
Niemeyer, Charlotte M
Villunger, Andreas
Erlacher, Miriam
Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
author_facet Labi, Verena
Bertele, Daniela
Woess, Claudia
Tischner, Denise
Bock, Florian J
Schwemmers, Sven
Pahl, Heike L
Geley, Stephan
Kunze, Mirjam
Niemeyer, Charlotte M
Villunger, Andreas
Erlacher, Miriam
author_sort Labi, Verena
title Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
title_short Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
title_full Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
title_fullStr Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
title_full_unstemmed Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
title_sort haematopoietic stem cell survival and transplantation efficacy is limited by the bh3-only proteins bim and bmf
description Anti-apoptotic Bcl-2 family members are critical for the regulation of haematopoietic stem and progenitor cell (HSPC) survival. Little is known about the role of their pro-apoptotic antagonists, i.e. ‘BH3-only’ proteins, in this cell compartment. Based on the analysis of cytokine deprivation-induced changes in mRNA expression levels of Bcl-2 family proteins, we determined the consequences of BH3-only protein depletion on HSPC survival in culture and, for selected candidates, on engraftment in vivo. Thereby, we revealed a critical role for Bim and Bmf as regulators of HSPC dynamics both during early engraftment and long-term reconstitution. HSPCs derived from wild-type donors were readily displaced by Bim- or Bmf-deficient or Bcl-2-overexpressing HSPCs as early as 10 days after engraftment. Moreover, in the absence of Bim, significantly lower numbers of transplanted HSPCs were able to fully engraft radio-depleted recipients. Finally, we provide proof of principle that RNAi-based reduction of BIM or BMF, or overexpression of BCL-2 in human CD34+ cord blood cells may be an attractive therapeutic option to increase stem cell survival and transplantation efficacy.
publisher WILEY-VCH Verlag
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569658/
_version_ 1611954017181630464